Your browser doesn't support javascript.
loading
Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction.
Biering, Scott B; Akey, David L; Wong, Marcus P; Brown, W Clay; Lo, Nicholas T N; Puerta-Guardo, Henry; Tramontini Gomes de Sousa, Francielle; Wang, Chunling; Konwerski, Jamie R; Espinosa, Diego A; Bockhaus, Nicholas J; Glasner, Dustin R; Li, Jeffrey; Blanc, Sophie F; Juan, Evan Y; Elledge, Stephen J; Mina, Michael J; Beatty, P Robert; Smith, Janet L; Harris, Eva.
Afiliación
  • Biering SB; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Akey DL; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Wong MP; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Brown WC; Infectious Diseases and Immunity Graduate Group, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Lo NTN; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Puerta-Guardo H; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Tramontini Gomes de Sousa F; Infectious Diseases and Immunity Graduate Group, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Wang C; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Konwerski JR; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Espinosa DA; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Bockhaus NJ; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Glasner DR; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Li J; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Blanc SF; Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
  • Juan EY; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Elledge SJ; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Mina MJ; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Beatty PR; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720-3370, USA.
  • Smith JL; Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Department of Genetics, and Program in Virology, Harvard Medical School, Boston, MA 02115, USA.
  • Harris E; Center for Communicable Disease Dynamics, Department of Epidemiology, and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Science ; 371(6525): 194-200, 2021 01 08.
Article en En | MEDLINE | ID: mdl-33414220
ABSTRACT
Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the ß-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus del Nilo Occidental / Proteínas no Estructurales Virales / Virus del Dengue / Anticuerpos Neutralizantes / Virus Zika / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus del Nilo Occidental / Proteínas no Estructurales Virales / Virus del Dengue / Anticuerpos Neutralizantes / Virus Zika / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article